Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	12.58	10.81	28.95	7.11	35.41	13.63
Short-Term Investments	91.38	159.64	158.84	17.3	0	0
Cash & Cash Equivalents	103.95	170.45	187.78	24.4	35.41	13.63
Cash Growth	-39.01%	-9.23%	669.51%	-31.08%	159.72%	-
Other Current Assets	1.75	2.29	1.38	0.96	0.49	0.47
Total Current Assets	105.71	172.75	189.16	25.36	35.9	14.1
Property, Plant & Equipment	24.08	28.53	30.6	16.35	11.52	1.44
Long-Term Investments	26.41	23.94	85.35	0	0	0
Other Long-Term Assets	3.59	2.59	2.61	4.83	1.03	0.43
Total Long-Term Assets	54.08	55.06	118.56	21.18	12.55	1.88
Total Assets	159.78	227.81	307.72	46.54	48.45	15.98
Accounts Payable	2.99	3.59	3.57	1.6	2.1	0.89
Deferred Revenue	11.31	14.91	17.08	1.5	1.57	0
Current Debt	2.78	2.39	2.5	1.5	3.1	0.04
Other Current Liabilities	3.38	2.22	-1.82	6.66	1.89	1.82
Total Current Liabilities	20.46	23.12	21.33	11.26	8.66	2.76
Long-Term Debt	17.44	20.22	21.85	9.38	7.09	0
Other Long-Term Liabilities	9.15	12.96	14.42	25.55	1.04	0.8
Total Long-Term Liabilities	26.59	33.18	36.27	34.93	8.13	0.8
Total Liabilities	47.04	56.3	57.6	46.19	16.79	3.55
Total Debt	20.22	22.61	24.36	10.88	10.19	0.04
Debt Growth	-10.58%	-7.16%	123.91%	6.79%	25362.50%	-
Retained Earnings	-364.29	-295.09	-206.99	-108.4	-47.67	-17.18
Comprehensive Income	0.04	-0.92	-0.32	0	0	0
Shareholders' Equity	112.74	171.51	250.12	-104.95	-45.85	-15.94
Net Cash / Debt	83.74	147.84	163.43	13.53	25.23	13.59
Net Cash / Debt Growth	-43.36%	-9.54%	1108.26%	-46.38%	85.56%	-
Net Cash Per Share	2.21	3.96	4.92	6.43	12.65	8.23
Working Capital	85.25	149.63	167.83	14.1	27.24	11.35
Book Value Per Share	2.98	4.59	7.53	-49.92	-23.00	-9.66

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).